Abstract
Children with Crohn disease have altered growth and body composition. Previous studies have demonstrated decreased protein breakdown after either corticosteroid or anti-TNF-α therapy. The aim of this study was to evaluate whole body protein metabolism during corticosteroid therapy in children with newly diagnosed Crohn disease. Children with suspected Crohn disease and children with abdominal symptoms not consistent with Crohn disease underwent outpatient metabolic assessment. Patients diagnosed with Crohn disease and prescribed corticosteroid therapy returned in 2 wk for repeat metabolic assessment. Using the stable isotopes [d5] phenylalanine, [1-13C] leucine, and [15N2] urea, protein kinetics were determined in the fasting state. Thirty-one children (18 controls and 13 newly diagnosed with Crohn disease) completed the study. There were no significant differences in protein breakdown or loss between patients with Crohn disease at diagnosis and controls. After corticosteroid therapy in patients with Crohn disease, the rates of appearance of phenylalanine (32%) and leucine (26%) increased significantly, reflecting increased protein breakdown, and the rate of appearance of urea also increased significantly (273%), reflecting increased protein loss. Whole body protein breakdown and loss increased significantly after 2 wk of corticosteroid therapy in children with newly diagnosed Crohn disease, which may have profound effects on body composition.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ESR:
-
erythrocyte sedimentation rate
- I Phe :
-
infusion rate of tracer phenylalanine
- KIC:
-
a-ketoisocaproic acid
- PCDAI:
-
pediatric Crohn disease activity index
- Q PT :
-
phenylalanine hydroxylation to tyrosine
- R a :
-
rate of appearance
References
Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS 2000 Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 31: 33–40
Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T, Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T 2009 A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease. Clin Gastroenterol Hepatol 7: 452–455
Thayu M, Denson LA, Shults J, Zemel BS, Burnham JM, Baldassano RN, Howard KM, Ryan A, Leonard MB 2010 Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology 139: 430–438
Golden MH, Waterlow JC, Picou D 1977 Protein turnover, synthesis and breakdown before and after recovery from protein-energy malnutrition. Clin Sci Mol Med 53: 473–477
Jackson AA, Doherty J, de Benoist MH, Hibbert J, Persaud C 1990 The effect of the level of dietary protein, carbohydrate and fat on urea kinetics in young children during rapid catch-up weight gain. Br J Nutr 64: 371–385
Starnes HF Jr, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF 1988 Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 82: 1321–1325
Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB 2004 Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19: 1961–1968
Powell-Tuck J, Garlick PJ, Lennard-Jones JE, Waterlow JC 1984 Rates of whole body protein synthesis and breakdown increase with the severity of inflammatory bowel disease. Gut 25: 460–464
Thomas AG, Miller V, Taylor F, Maycock P, Scrimgeour CM, Rennie MJ 1992 Whole body protein turnover in childhood Crohn's disease. Gut 33: 675–677
Steiner SJ, Pfefferkorn MD, Fitzgerald JF, Denne SC 2007 Protein and energy metabolism response to the initial dose of infliximab in children with Crohn's disease. Inflamm Bowel Dis 13: 737–744
Burt MG, Johannsson G, Umpleby AM, Chisholm DJ, Ho KK 2007 Impact of acute and chronic low-dose glucocorticoids on protein metabolism. J Clin Endocrinol Metab 92: 3923–3929
Beaufrere B, Horber FF, Schwenk WF, Marsh HM, Matthews D, Gerich JE, Haymond MW 1989 Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol 257: E712–E721
Burt MG, Gibney J, Ho KK 2007 Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment. Am J Physiol Endocrinol Metab 292: E1426–E1432
Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Grand RJ, Boyle JT, Michener WM, Levy JS, Lesser ML 1991 Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12: 439–447
Denne SC, Karn CA, Wang J, Liechty EA 1995 Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns. Am J Physiol 269: E361–E367
Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW 1984 Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem 141: 101–109
Wolfe RR 1992 Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. Wiley-Liss: New York, NY p 471
Steele R 1959 Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82: 420–430
Tserng KY, Kalhan SC 1983 Calculation of substrate turnover rate in stable isotope tracer studies. Am J Physiol 245: E308–E311
Thompson GN, Pacy PJ, Merritt H, Ford GC, Read MA, Cheng KN, Halliday D 1989 Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model. Am J Physiol 256: E631–E639
Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E, Wahren J 1995 Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 95: 2926–2937
Azcue M, Rashid M, Griffiths A, Pencharz PB 1997 Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 41: 203–208
Walters TD, Gilman AR, Griffiths AM 2007 Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis 13: 424–430
Devlin SM, Panaccione R, Devlin SM, Panaccione R 2009 Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up. Gastroenterol Clin North Am 38: 577–594
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a Clarian Values Award and National Institutes of Health Grant NIH 1 K23 RR021343-01A1 [S.J.S.].
The authors report no conflicts of interest.
Rights and permissions
About this article
Cite this article
Steiner, S., Noe, J. & Denne, S. Corticosteroids Increase Protein Breakdown and Loss in Newly Diagnosed Pediatric Crohn Disease. Pediatr Res 70, 484–488 (2011). https://doi.org/10.1203/PDR.0b013e31822f5886
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e31822f5886
